Helena Edlund is a Swedish professor and molecular biologist. She received her Ph.D. from Umeå University in 1991.[1] She is a professor in Molecular Developmental Biology at Umeå University where she researches Type 2 diabetes and β-cell function.[2] She is one of the founders, along with Thomas Edlund and Olof Karlsson, of the biopharmaceutical company Betagenon.[3]
In 2000, Edlund was the recipient of the Minkowski Prize given by the European Association for the Study of Diabetes (EASD) for her work in factors controlling beta-cell identity and glucose homeostasis.[4] She is a member of the Royal Swedish Academy of Sciences. She has written numerous articles on beta cell differentiation, beta cell function, pancreatic development, and Type 2 diabetes.[1]
References edit
- ^ a b "Helena Edlund". ORCID. Retrieved 4 November 2021.
- ^ "Grp Helena Edlund". Umeå University. Retrieved 4 November 2021.
- ^ "Management". Betagenon. Retrieved 4 November 2021.
- ^ "Minkowski". EASD. Retrieved 4 November 2021.
External links edit
- Mini CV Helana Edlund Scientific Advisory Board, Oslo University Hospital
 | This article about a Swedish scientist is a stub. You can help Wikipedia by expanding it. |